Khaldoun M Al-rayess, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2121 N 1700 W, Layton, UT 84041 Phone: 801-773-4840 Fax: 801-525-8151 |
Mr. Brett Michael Rawlins, FNP Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 201 W Layton Pkwy Ste 4c, Layton, UT 84041 Phone: 801-475-3280 |
Kelly Presnell, FNP-BC Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2121 N 1700 W, Layton, UT 84041 Phone: 801-773-4840 Fax: 801-525-8151 |
Dr. Steven Lee Brown, D.O. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2121 N 1700 W, Layton, UT 84041 Phone: 801-773-4840 Fax: 801-525-8167 |
News Archive
The antiretroviral (ARV) drug atazanavir—sometimes included in treatments to prevent mother-to-child HIV transmission during pregnancy—may have small but significant effects on infant development, reports a study in the journal AIDS, official journal of the International AIDS Society.
Health Affairs: Many Emergency Department Visits Could Be Managed At Urgent Care Centers And Retail Clinics - Researchers analyzed samples of patient records and found "13.7 percent of all emergency department visits could take place at a retail clinic" - 7.9 percent when hours are restricted - and "an additional 13.4 percent of emergency department visits could take place at a urgent care center—8.9 percent when hours are restricted.
The first U.S. study to transplant a potent form of purified adult stem cells into the heart muscle of patients with severe angina provided evidence that the procedure is safe and produced a reduction in angina pain as well as improved functioning in patients' daily lives, reports the lead researcher at Northwestern University's Feinberg School of Medicine.
Revolutions Medical Corporation today announced that the Company has finalized a manufacturing agreement with Medical Investment Group ("MIG"). Pursuant to the Manufacturing Agreement, MIG has guaranteed the production and delivery of a minimum of five million 3cc safety syringes per month for a period of five years.
› Verified 1 days ago